trust

EXPERIENCE

10+ Yrs

LANGUAGES

English

PATIENTS

Helped 1000 patients

FEE

QUERY

$19.99

PHONE/VIDEO

$29.99

Recent Answers
Recent Answers

Professional Bio

Professional Bio

I'm a Radiation Oncologist, and I did my M.D from King George's Medical University, Lucknow, India (Graduated in 2016). Presently, I'm working in National Cancer Center Hospital East, Japan since last 2 years. I treat all cancer subsite using photon and proton therapy. My main focus/research area is using Proton therapy for head and neck and gastrointestinal malignancy.

Academics & Trainings

Academics & Trainings

Education

M.D. (RADIATION ONCOLOGY)

King George's Medical University, Lucknow

2016


Education

D.N.B. (RADIATION ONCOLOGY)

Directorate Of National Board, Delhi

2018

Awards & Publications

Awards & Publications

1> Visiting Scientist (Particle therapy and Translational Research) in National Cancer Center Hospital East, Chiba, Japan (17/06/2018 till 30/05/2019) 2> Research Assocate (Particle therapy) in National Cancer Center Hospital East, Chiba, Japan (01/06/2019 till date) 3> Publications: a> Multiple Inherited Schwannomas, Meningiomas, and Ependymomas Syndrome in an Adult Patient b> A Prospective Randomized Comparison of Concurrent Chemoradiation with Neoadjuvant and Adjuvant Chemotherapy with Concurrent Chemoradiation Alone for Locally Advanced Carcinoma Cervix c> Affiliation of XRCC-1 Gene Arg194Trp polymorphism in alcohol and tobacco substance users and loco-regionally progressed LSCC. d> A Prospective Study Comparing Oxaliplatin & 5-Fu with Gemcitabine & Cisplatin in Advanced Stage Carcinoma Gall Bladder e> A Prospective Randomized Comparison of Concurrent Chemoradiation with Neoadjuvant and Adjuvant Chemotherapy with Concurrent Chemoradiation Alone for Locally Advanced Carcinoma Cervix f> Hypofractionated proton beam therapy for centrally located lung cancer g> Impact of Proton Beam Irradiation of an Anatomic Subsegment of the Liver for Hepatocellular Carcinoma h> Could excision repair cross-complementing group-1mRNA expression from peripheral blood lymphocytes predict locoregional failure with cisplatin chemoradiation for locally advanced laryngeal cancer? i> Prospective evaluation of XRCC‐1 Arg194Trp polymorphism as bio‐predictor for clinical outcome in locally advanced laryngeal cancer undergoing cisplatin‐based chemoradiation j> Efficacy and safety of accelerated fractionated radiotherapy without elective nodal irradiation for T3N0 glottic cancer without vocal cord fixation k> Prospective evaluation of the setup errors and its impact on safety margin for cervical cancer pelvic conformal radiotherapy l> Treatment patterns and outcomes change in early-stage non-small cell lung cancer in octogenarians and older: a SEER database analysis

Testimonials

In-Person Consultation

Vijay Raturi

Division Of Radiation Oncology And Particle Therapy, National Cancer Center Hospital East, 6 Chome-5-1 Kashiwanoha,, Kashiwa, Chiba, Zip: 2278577, JP